slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 72,151-72,180
Pages 3,679
Rows per page 30
Component
72,151-72,180 of 110,355
26
The chart highlights a specific patient case with a partial response (PR) and notes a suboptimal dose case.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
27
Uses a 2x2 grid of metrics to frame the problem space.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
29
The slide uses a funnel-like logic to narrow down from total prevalence to a specific addressable patient population for a 2L+ therapy.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
32
The table compares dosing schedules for a clinical trial drug.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
33
BA3021 Ozuriftamab VedotinBioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
35
The slide uses a combination of a summary table for clinical endpoints and a dot plot for NHP toxicity data.BioAtla | Investor Presentation Deck | 43 slides · BioAtla
Pitch deck Investor relations Beat · Roadmap1 hit
05
The slide uses a central white box overlay on a split-image background (food scene and delivery scene).Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations 1 hit
10
The slide highlights both year-over-year and quarter-over-quarter margin growth.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations 1 hit
12
The slide uses a background of sliced tomatoes, likely a brand-related visual element for Blue Apron.Blue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations Loop · Voice Of Customer1 hit
07
The slide uses a culinary-themed background, likely reflecting the company's industry (food/grocery).Blue Apron | Results Presentation Deck | 24 slides · Blue Apron
Conference presentation Investor relations Beat · AttentionLoop · Cost Of Inaction1 hit
14
The slide compares margin percentage trends against absolute PTG&A dollar trends.Blue Apron | Results Presentation Deck | 24 slides · Blue Apron
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
The Q2 '23 Net Loss bar includes a specific footnote regarding the FreshRealm transaction impact.Blue Apron | Results Presentation Deck | 24 slides · Blue Apron
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
03
The slide uses a horizontal list format to present five key pillars of the company's business model.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
04
Uses a comparative structure to contrast Sepsis vs Septic Shock, followed by impact metrics.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a problem-solution framing, identifying the 'why' (IL-6 is good) and the 'but' (it's unstable), leading to the company's value proposition at the bottom.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The table provides a bottom-up calculation of TAM based on patient volume, test frequency, and pricing, with a projected uplift from the company's product.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
11
The table highlights NPV as the key differentiator. The ROC chart visually confirms IL-6's superior AUC.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
The table uses a direct feature-by-feature comparison to establish competitive differentiation.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
The slide uses a 3x2 grid layout to present key performance indicators and strategic updates.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
08
The slide contains two distinct tables: one for absolute member counts and one for percentage of total members.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
11
The slide presents two distinct tables: one for percentage ratios and one for YoY basis point changes.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations Beat · FinancialsLoop · Pareto Focus1 hit
13
Includes a table of medical centers by state and a summary table of key metrics (states, centers, members) over time.Cano Health | Results Presentation Deck | 13 slides · Cano Health
Conference presentation Investor relations 1 hit
04
The slide uses a Gantt-style chart to represent drug development progress.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations 1 hit
06
Includes a Kaplan-Meier survival curve, an anatomical illustration of tumor locations, and a comparative table of clinical outcomes.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide highlights clinical trial results with specific response and disease control rates for two different RANO criteria.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
10
The chart is a waterfall plot (often called a swimmer plot or spider plot in oncology, though technically a waterfall).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
11
The chart is a waterfall plot showing Best % Change in SPD from Baseline. The legend indicates PS scores (060-100).Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
13
Data presented in two tables comparing healthy adult dose escalation vs glioma patient safety profiles.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
14
The slide highlights the correlation between RANO response criteria and improved clinical outcomes in H3 K27M-mutant DMG patients.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
17
The slide uses a process flow diagram to illustrate the trial structure.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit